448 results on '"Ostermann, Helmut"'
Search Results
2. PET-guided eBEACOPP treatment of advanced-stage Hodgkin lymphoma (HD18): follow-up analysis of an international, open-label, randomised, phase 3 trial
3. PET-guided omission of radiotherapy in early-stage unfavourable Hodgkin lymphoma (GHSG HD17): a multicentre, open-label, randomised, phase 3 trial
4. Patient-reported measures of well-being in older multiple myeloma patients: use of secondary data source
5. Multiple Myeloma Treatment in Real-world Clinical Practice: Results of a Prospective, Multinational, Noninterventional Study
6. Improving quality of antifungal use through antifungal stewardship interventions
7. PET-guided treatment in patients with advanced-stage Hodgkin's lymphoma (HD18): final results of an open-label, international, randomised phase 3 trial by the German Hodgkin Study Group
8. Progression-free survival of early interim PET-positive patients with advanced stage Hodgkin's lymphoma treated with BEACOPPescalated alone or in combination with rituximab (HD18): an open-label, international, randomised phase 3 study by the German Hodgkin Study Group
9. Phase 1b safety and pharmacokinetics of intravenous and oral fosmanogepix in patients with acute myeloid leukaemia and neutropenia.
10. Burden of oral mucositis in stem cell transplant patients—the patients’ perspective
11. Plerixafor in poor mobilizers with non-Hodgkin’s lymphoma: a multi-center time-motion analysis
12. Primary prophylaxis of invasive fungal infections in patients with haematological malignancies: 2017 update of the recommendations of the Infectious Diseases Working Party (AGIHO) of the German Society for Haematology and Medical Oncology (DGHO)
13. Expert Report on Immune Thrombocytopenia - Current Diagnostics and Treatment Recommendations from an Expert Group from Austria, Germany, and Switzerland
14. Expertenreport Immunthrombozytopenie - Aktuelle Diagnostik und Therapie
15. JAK inhibition with ruxolitinib in relapsed or refractory classical Hodgkin lymphoma: Final results of a phase II, open label, multicentre clinical trial (JeRiCHO)
16. Reactivation of polyomavirus in the genitourinary tract is significantly associated with severe GvHD and oral mucositis following allogeneic stem cell transplantation
17. Economic and clinical aspects of intravenous versus oral busulfan in adult patients for conditioning prior to HSCT
18. Usability of German hospital administrative claims data for healthcare research: General assessment and use case of multiple myeloma in Munich university hospital in 2015–2017
19. JAK inhibition with ruxolitinib in relapsed or refractory classical Hodgkin lymphoma: Final results of a phase II, open label, multicentre clinical trial (JeRiCHO)
20. Antifungal prophylaxis in newly diagnosed AML patients–Adherence to guidelines and feasibility in a real life setting
21. Expertenreport Immunthrombozytopenie – Aktuelle Diagnostik und Therapie.
22. Transparency on Platelet Transfusion in Routine Cancer Care: The Key for Optimal Blood Usage?
23. Primary prophylaxis of invasive fungal infections in patients with haematologic malignancies. 2014 update of the recommendations of the Infectious Diseases Working Party of the German Society for Haematology and Oncology
24. Management of sepsis in neutropenic patients: 2014 updated guidelines from the Infectious Diseases Working Party of the German Society of Hematology and Medical Oncology (AGIHO)
25. Treatment of invasive fungal infections in cancer patients—updated recommendations of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Oncology (DGHO)
26. Matched-paired analysis of patients treated for invasive mucormycosis: standard treatment versus posaconazole new formulations (MoveOn)
27. Pseudomonas aeruginosa Nosocomial Pneumonia: Impact of Pneumonia Classification
28. Workshop - Ökonomische Steuerungsmechanismen: Beispiel Hämatologie und Onkologie
29. An international multicenter retrospective study of Pseudomonas aeruginosa nosocomial pneumonia: impact of multidrug resistance
30. Leitlinie : Empfehlungen der Fachgesellschaft zur Diagnostik und Therapie h��matologischer und onkologischer Erkrankungen : ICD10: D69.3
31. Stellungnahme zur Nutzenbewertung des G-BA von Arzneimitteln gemäß § 35a SGB V, veröffentlicht am 1. Juli 2021, Vorgangsnummer 2021-04-01-D-649, IQWiG Bericht Nr. 1148
32. Reciprocal Changes in Circulating Interleukin-6 and Its Soluble Receptor during Evolving Sepsis in Leukocytopenic Patients
33. Impact of infusion speed on the safety and effectiveness of prothrombin complex concentrate: A prospective clinical trial of emergency anticoagulation reversal
34. A clinical cohort trial of antifungal combination therapy: efficacy and toxicity in haematological cancer patients
35. Posaconazole prophylaxis – impact on incidence of invasive fungal disease and antifungal treatment in haematological patients
36. Stellungnahme zur Nutzenbewertung des G-BA von Arzneimitteln gemäß § 35a SGB V, veröffentlicht am 1. Oktober 2020, Vorgangsnummer 2020-07-01-D-556, IQWiG Bericht Nr. 975
37. Leitlinie : Empfehlungen der Fachgesellschaft zur Diagnostik und Therapie hämatologischer und onkologischer Erkrankungen : ICD10: D69.3
38. Management of sepsis in neutropenia: guidelines of the infectious diseases working party (AGIHO) of the German Society of Hematology and Oncology (DGHO)
39. Psychoonkologie und DRG-Fallpauschalen
40. Dokumentation und Kodierung psychoonkologischer Leistungen
41. Autorenverzeichnis
42. Sepsis in neutropenia: Guidelines of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Oncology (DGHO)
43. Model Calculations to Quantify Clinical and Economic Effects of Pathogen Inactivation in Platelet Concentrates
44. A Retrospective Observational Single-Centre Study on the Burden of Immune Thrombocytopenia (ITP)
45. An on-line solid phase extraction procedure for the routine quantification of caspofungin by liquid chromatography-tandem mass spectrometry
46. Primary effusion lymphoma (PEL) without effusion: a patient case report of a PEL solid variant
47. Steroids in neutropenic patients with sepsis – comment on How I manage haematology patients with septic shock by Jon Cohen and Stephen Drage
48. Classification of invasive fungal disease in patients with acute myeloid leukaemia
49. Patterns of Renal Recovery and Toxicity with Novel Agent-Based Induction Triplets in Newly Diagnosed Multiple Myeloma - an Analysis of Two Prospective Studies By the German DSMM Myeloma Study Group
50. Diagnostik und Therapie der Immunthrombozytopenie: Empfehlungen einer gemeinsamen Expertengruppe der DGHO, DGTI und GTH
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.